
American Well Corporation (AMWL)
$
5.28
-0.23 (-4.36%)
Key metrics
Financial statements
Free cash flow per share
-4.0228
Market cap
87.4 Million
Price to sales ratio
0.3505
Debt to equity
0.0192
Current ratio
3.3693
Income quality
0.6963
Average inventory
1.5 Million
ROE
-0.3588
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
American Well Corporation operates as a telehealth software company that facilitates the digital delivery of healthcare services. The financial data pertains to the fiscal year 2025 with the company reporting total costs and expenses of $354,599,000.00 reflecting its overall spending. Additionally, the company reported selling, general, and administrative expenses of $131,310,000.00 indicating its operational overhead costs. It also reported depreciation and amortization expenses of $33,961,000.00 which reflects the wear and tear of its assets. Furthermore, the company showcased its pre-tax profitability by reporting an income before tax of -$94,533,000.00. The company’s product offerings include urgent care, scheduled visits, acute behavioral health, telestroke, pediatrics, and services tailored for retail health, school health, and home settings. Its application caters to various healthcare needs such as pediatrics, therapy, menopause nutrition, end-stage renal disease and dialysis, dermatology care, behavioral health therapy, and musculoskeletal care. American Well also supplies telemedicine equipment, which includes telemedicine carts, peripherals, Tyto care, TV kits, tablets, and kiosks. Founded in 2006, the company is headquartered in Boston, Massachusetts. In the stock market, the company presents an appealing investment opportunity, with the stock being affordable at $6.42 making it suitable for budget-conscious investors. Under the financial umbrella, it has a low average trading volume of 98,750.00 indicating lower market activity, which may attract a certain type of investment strategy. With a market capitalization of $87,393,552.00 the company is classified as a small-cap player, positioning it in a niche category that often holds potential for growth. It is a key player in the Medical - Healthcare Information Services industry, contributing significantly to the overall market landscape and driving forward innovation and growth within the field. As part of the Healthcare sector, American Well Corporation not only represents a unique investment but also plays a critical role in advancing healthcare accessibility through its telehealth solutions.
Investing in American Well Corporation (AMWL) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict American Well Corporation stock to fluctuate between $3.71 (low) and $9.15 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-03-27, American Well Corporation's market cap is $87,393,552, based on 16,551,809 outstanding shares.
Compared to Meta Platforms, Inc. Class A Common Stock, American Well Corporation has a Lower Market-Cap, indicating a difference in performance.
To buy American Well Corporation (AMWL) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AMWL. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
American Well Corporation's last stock split was 1:20 on 2024-07-11.
Revenue: $249,325,000 | EPS: -$5.96 | Growth: -57.06%.
Visit https://amwell.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $233.60 (2021-08-06) | All-time low: $3.71 (2025-11-21).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

zacks.com
Here is how American Well Corporation (AMWL) and Annexon, Inc. (ANNX) have performed compared to their sector so far this year.

zacks.com
Here is how American Well Corporation (AMWL) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.

zacks.com
GRMN, HLF and AMWL stand out in a booming wellness market as wearables, nutrition products and telehealth platforms reshape how consumers pursue healthier lives.

globenewswire.com
BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announced that on February 18, Amwell made a grant of RSUs of 61,559 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee's employment with Amwell. The RSUs will vest as follows, subject to the employee's continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date (“Initial Vesting Date”), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date) for three years until such RSUs are vested in full.

zacks.com
American Well (AMWL) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

seekingalpha.com
American Well Corporation (AMWL) Q4 2025 Earnings Call Transcript

zacks.com
The headline numbers for American Well (AMWL) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

seekingalpha.com
American Well Corporation ( AMWL ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ido Schoenberg - Chairman & CEO Mark Hirschhorn - Executive VP, COO & CFO Conference Call Participants Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division Charles Rhyee - TD Cowen, Research Division Jenny Cao - Truist Securities, Inc., Research Division Jack Senft - UBS Investment Bank, Research Division John Park - Morgan Stanley, Research Division Presentation Operator " Ido Schoenberg Chairman & CEO " Mark Hirschhorn Executive VP, COO & CFO " Stanislav Berenshteyn Wells Fargo Securities, LLC, Research Division " Wells Fargo Securities, LLC, Research Division Charles Rhyee TD Cowen, Research Division " TD Cowen, Research Division Jenny Cao Truist Securities, Inc., Research Division " Truist Securities, Inc., Research Division Jack Senft UBS Investment Bank, Research Division " UBS Investment Bank, Research Division John Park Morgan Stanley, Research Division " Morgan Stanley, Research Division Operator Hello, everyone, and welcome to Amwell's conference call to discuss their third fiscal quarter of 2025. Joining us on the call today are Amwell's Chairman and CEO, Dr. Ido Schoenberg; and Mark Hirschhorn, Amwell's CFO and Chief Operating Officer.

zacks.com
While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com
American Well Corporation (AMWL) came out with a quarterly loss of $1.74 per share versus the Zacks Consensus Estimate of a loss of $1.83. This compares to a loss of $2.87 per share a year ago.
See all news